Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gad Getz

Showing results (221-230 of 397) with videos related to

Pageof 40
Sort By:
Nature Genetics|August 22, 2017
A mutational signature reveals alterations underlying deficient homologous recombination repair in breast cancerPaz Polak, Jaegil Kim, Lior Z Braunstein, et al.
Cancer Cell|December 13, 2017
High-throughput Phenotyping of Lung Cancer Somatic MutationsAlice H Berger, Angela N Brooks, Xiaoyun Wu, et al.
Nature|August 10, 2018
Genetic and transcriptional evolution alters cancer cell line drug responseUri Ben-David, Benjamin Siranosian, Gavin Ha, et al.
Cancer Cell|August 2, 2016
High-throughput Phenotyping of Lung Cancer Somatic MutationsAlice H Berger, Angela N Brooks, Xiaoyun Wu, et al.
Nature Genetics|September 19, 2018
Mutational processes shape the landscape of TP53 mutations in human cancerAndrew O Giacomelli, Xiaoping Yang, Robert E Lintner, et al.
Cancer Discovery|February 13, 2015
Clinical Acquired Resistance to RAF Inhibitor Combinations in BRAF-Mutant Colorectal Cancer through MAPK Pathway AlterationsLeanne G Ahronian, Erin M Sennott, Eliezer M Van Allen, et al.
Blood|March 12, 2025
Large-scale dependency and drug screens characterize the therapeutic vulnerabilities of Multiple Myeloma with 1qRomanos Sklavenitis-Pistofidis, Elizabeth D Lightbody, Mairead Reidy, et al.
Cancer Immunology Research|May 28, 2015
Long-term Benefit of PD-L1 Blockade in Lung Cancer Associated with JAK3 ActivationEliezer M Van Allen, Hadrien G Golay, Yan Liu, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 13, 2011
Systematic investigation of genetic vulnerabilities across cancer cell lines reveals lineage-specific dependencies in ovarian cancerHiu Wing Cheung, Glenn S Cowley, Barbara A Weir, et al.
Cancer Discovery|November 18, 2020
The Lipogenic Regulator SREBP2 Induces Transferrin in Circulating Melanoma Cells and Suppresses FerroptosisXin Hong, Whijae Roh, Ryan J Sullivan, et al.
Pageof 40

Showing results (221-230 of 397) with videos related to

Sort By:
Pageof 40
Nature Genetics|August 22, 2017
A mutational signature reveals alterations underlying deficient homologous recombination repair in breast cancerPaz Polak, Jaegil Kim, Lior Z Braunstein, et al.
Cancer Cell|December 13, 2017
High-throughput Phenotyping of Lung Cancer Somatic MutationsAlice H Berger, Angela N Brooks, Xiaoyun Wu, et al.
Nature|August 10, 2018
Genetic and transcriptional evolution alters cancer cell line drug responseUri Ben-David, Benjamin Siranosian, Gavin Ha, et al.
Cancer Cell|August 2, 2016
High-throughput Phenotyping of Lung Cancer Somatic MutationsAlice H Berger, Angela N Brooks, Xiaoyun Wu, et al.
Nature Genetics|September 19, 2018
Mutational processes shape the landscape of TP53 mutations in human cancerAndrew O Giacomelli, Xiaoping Yang, Robert E Lintner, et al.
Cancer Discovery|February 13, 2015
Clinical Acquired Resistance to RAF Inhibitor Combinations in BRAF-Mutant Colorectal Cancer through MAPK Pathway AlterationsLeanne G Ahronian, Erin M Sennott, Eliezer M Van Allen, et al.
Blood|March 12, 2025
Large-scale dependency and drug screens characterize the therapeutic vulnerabilities of Multiple Myeloma with 1qRomanos Sklavenitis-Pistofidis, Elizabeth D Lightbody, Mairead Reidy, et al.
Cancer Immunology Research|May 28, 2015
Long-term Benefit of PD-L1 Blockade in Lung Cancer Associated with JAK3 ActivationEliezer M Van Allen, Hadrien G Golay, Yan Liu, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 13, 2011
Systematic investigation of genetic vulnerabilities across cancer cell lines reveals lineage-specific dependencies in ovarian cancerHiu Wing Cheung, Glenn S Cowley, Barbara A Weir, et al.
Cancer Discovery|November 18, 2020
The Lipogenic Regulator SREBP2 Induces Transferrin in Circulating Melanoma Cells and Suppresses FerroptosisXin Hong, Whijae Roh, Ryan J Sullivan, et al.
Pageof 40